Misplaced Pages

This is an old revision of this page, as edited by BogBot (talk | contribs) at 14:07, 3 September 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

PWZ-029

Identifiers
IUPAC name 8-chloro-3-(methoxymethyl)-5-methyl-4H-imidazobenzodiazepin-6-one
PubChem CID	9971547
CompTox Dashboard (EPA)	DTXSID801028421
Chemical and physical data
Formula	C14H14ClN3O2
Molar mass	291.732 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES c3c(Cl)ccc-1c3C(=O)N(C)Cc2n-1cnc2COC
(verify)

PWZ-029 is a benzodiazepine derivative drug with nootropic effects. It acts as a subtype-selective, mixed agonist-inverse agonist at the benzodiazepine binding site on the GABA_A receptor, acting as a partial inverse agonist at the α₅ subtype and a weak partial agonist at the α₃ subtype. This gives it a mixed pharmacological profile, producing at low doses memory-enhancing effects but with no convulsant or anxiogenic effects or muscle weakness, although at higher doses it produces some sedative effects.

See also

• L-655,708
• α₅IA
• TB-21007

References

1. Savić MM, Clayton T, Furtmüller R, Gavrilović I, Samardzić J, Savić S, Huck S, Sieghart W, Cook JM. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats. Brain Research. 2008 May 7;1208:150-9. doi:10.1016/j.brainres.2008.02.020 PMID 18394590

This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• GABA antagonists
• Nootropics
• Organochlorides
• Lactams
• Imidazobenzodiazepines
• Ethers
• Nervous system drug stubs